Regentis Biomaterials prices $6.5 million private placement at $3.5 per share

Regentis Biomaterials Ltd

Regentis Biomaterials Ltd

RGNT

0.00
  • Regentis Biomaterials priced a USD 6.5 million private placement of ordinary shares or pre-funded warrants with accompanying warrants.
  • Deal set at USD 3.5 per ordinary share with a warrant; pre-funded warrants priced at USD 3.4999 with a USD 0.0001 exercise price.
  • Issuance totals 1,857,143 ordinary shares or pre-funded warrants; ordinary warrants cover 1,857,143 shares at a USD 4.2 exercise price.
  • Warrants are immediately exercisable; ordinary warrants run for five years. Closing expected on or about June 23, 2026.
  • Proceeds earmarked for GelrinC pivotal trial and FDA pre-market approval work, manufacturing scale-up, European market entry, working capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606172105ACCESSWRNAPR_____1178909) on June 18, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.